Cite
Sirolimus Decreases Circulating Lymphangioleiomyomatosis Cells in Patients With Lymphangioleiomyomatosis
MLA
Suowen Xu, et al. “Sirolimus Decreases Circulating Lymphangioleiomyomatosis Cells in Patients With Lymphangioleiomyomatosis.” Chest, vol. 145, Jan. 2014, pp. 108–12. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....8767e46eaa2705152537bab484dd668a&authtype=sso&custid=ns315887.
APA
Suowen Xu, J. Philip McCoy, Gustavo Pacheco-Rodriguez, Joel Moss, Mario Stylianou, Mary Haughey, Thomas N. Darling, Hai-Ping Wu, Xiong Cai, & Leigh Samsel. (2014). Sirolimus Decreases Circulating Lymphangioleiomyomatosis Cells in Patients With Lymphangioleiomyomatosis. Chest, 145, 108–112.
Chicago
Suowen Xu, J. Philip McCoy, Gustavo Pacheco-Rodriguez, Joel Moss, Mario Stylianou, Mary Haughey, Thomas N. Darling, Hai-Ping Wu, Xiong Cai, and Leigh Samsel. 2014. “Sirolimus Decreases Circulating Lymphangioleiomyomatosis Cells in Patients With Lymphangioleiomyomatosis.” Chest 145 (January): 108–12. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....8767e46eaa2705152537bab484dd668a&authtype=sso&custid=ns315887.